Baluran, Merlyn N.

HRN: 24-42-16  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/14/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/14/2024
07/20/2024
IV
4.5 G Now Then 2.25 G
Q8
Septic Shock
Waiting Final Action 
07/14/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/14/2024
07/21/2024
IV
600mg
Q8
Non Healing Wound
Waiting Final Action 
07/15/2024
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
07/15/2024
07/22/2024
IVT
400mg LD, 100mg
OD
Infected DM Foot, Right
Waiting Final Action 
07/23/2024
CEFTAZIDIME 1GM (VIAL)
07/23/2024
07/30/2024
IV
1g
Q8H
HAP
Waiting Final Action 
07/23/2024
LEVOFLOXACIN 500MG (TAB)
07/23/2024
07/30/2024
ORAL
1/2 Tab
OD
HAP
Waiting Final Action 
07/23/2024
CEFTAZIDIME 1GM (VIAL)
07/23/2024
07/30/2024
IV
1
Q8hrs
HAP; Infected Wound
Waiting Final Action 
07/23/2024
LEVOFLOXACIN 500MG (TAB)
07/23/2024
07/30/2024
PO
500
Q24
HAP
Waiting Final Action 
07/23/2024
LEVOFLOXACIN 500MG (TAB)
07/23/2024
07/29/2024
PO
750 Mg =1 1/2 Tab
OD
Hap
Waiting Final Action 
08/05/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/05/2024
08/12/2024
IV
4.5 Grams
Every 6 Hours
Infected DM Foot
Waiting Final Action 
08/05/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/05/2024
08/12/2024
IV
600mg
Every 6 Hours
Infected DM Foot
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: